CIC Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$3.13M Buy
3,531
+324
+10% +$291K 0.81% 31
2024
Q2
$2.9M Buy
3,207
+73
+2% +$58.4K 0.8% 32
2024
Q1
$2.44M Buy
3,134
+227
+8% +$162K 0.71% 33
2023
Q4
$1.69M Buy
2,907
+1,007
+53% +$588K 0.54% 44
2023
Q3
$1.02M Buy
1,900
+1,302
+218% +$671K 0.37% 58
2023
Q2
$280K Buy
+598
New +$251K 0.1% 118
2023
Q1
Sell
-575
Closed -$210K 166
2022
Q4
$210K Buy
+575
New +$204K 0.09% 155

Other funds holding LLY

CIC Wealth's LLY Position: Q3 2024 in Review

CIC Wealth increased its Eli Lilly (LLY) stake by 10% in Q3 2024, buying an estimated $291K and bringing the position to 3,531 shares worth $3.13M. The position accounts for 0.81% of the portfolio, ranked #31.

CIC Wealth first reported a position in LLY in Q4 2022 and has held it in 7 quarters since. 3,663 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • CIC Wealth held 3,531 shares of Eli Lilly worth $3.13M as of Q3 2024.
  • CIC Wealth bought 324 Eli Lilly shares in Q3 2024, an estimated $291K.
  • Eli Lilly made up 0.81% of CIC Wealth's portfolio in Q3 2024, its #31 holding.
  • CIC Wealth first reported a position in Eli Lilly in Q4 2022 and has held it in 7 quarters since.
  • 3,663 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on CIC Wealth's 13F filing for Q3 2024, filed 8 Nov 2024.